Synthesis of New 4,5‐Dihydro‐3(2H)‐pyridazinone Derivatives

References

• Burnier , M. 2001 . Angiotensin II type 1 receptor blockers . Circulation , 103 ( 6 ) : 904 – 912 . [PUBMED] [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Goodfriend , T. L. 2000 . Angiotensin receptors: history and mysteries . Am. J. Hypertens. , 13 ( 4 ) : 442 – 449 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wexler , R. R. , Greenlee , W. J. , Irvin , J. D. , Goldberg , M. R. , Prendergast , K. , Smith , R. D. and Timmermans , P. B.M.W.M. 1996 . Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy . J. Med. Chem. , 39 ( 3 ) : 625 – 656 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kurup , A. , Garg , R. , Carini , D. J. and Hansch , C. 2001 . Comparative QSAR: angiotensin II antagonists . Chem. Rev. , 101 ( 9 ) : 2727 – 2750 . [PUBMED] [INFOTRIEVE] [CROSSREF]
   Google Scholar
• Krovat , E. M. and Langer , T. J. 2003 . Non‐peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification . J. Med. Chem. , 46 ( 5 ) : 716 – 726 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   Google Scholar
• Schmidt , B. and Schieffer , B. 2003 . Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites . J. Med. Chem. , 46 ( 12 ) : 2261 – 2270 . [PUBMED] [INFOTRIEVE] [CSA] [CROSSREF]
   Google Scholar
• Keenan , R. M. , Weinstock , J. , Finkelstein , J. A. , Franz , R. G. , Gaitanopoulos , D. E. , Girard , G. R. , Hill , D. T. , Morgan , T. M. , Samanen , J. M. , Peishoff , C. E. , Tucker , L. M. , Aiyar , N. , Griffin , E. , Ohlstein , E. H. , Stack , E. J. , Weidley , E. F. and Edwards , R. M. 1993 . Potent nonpeptide angiotensin II receptor antagonists. 2. 1‐(Carboxybenzyl)imidazole‐5‐acrylic acids . J. Med. Chem. , 36 ( 13 ) : 1880 – 1892 . [PUBMED] [INFOTRIEVE]
   Google Scholar
• Meyer , E. , Joussef , A. C. and Gallardo , H. 2003 . Synthesis of new 1,2,4‐ and 1,3,4‐oxadiazole derivatives . Synthesis , : 899 – 905 .
   Google Scholar
• Meyer , E. , Joussef , A. C. , Gallardo , H. and Bortoluzzi , A. J. 2003 . Structural characterization of two oxadiazolic systems used as spacers for potential angiotensin II receptor antagonists . J. Mol. Struc. , 655 : 361 – 368 . [CROSSREF]
   Web of Science ®Google Scholar
• Tóth , G. and Kövér , K. E. 1995 . Simple, safe, large scale synthesis of 5‐arylmethyl‐2,2‐dimethyl‐1,3‐dioxane‐4,6‐diones and 3‐arylpropanoic acids . Synth. Commun. , 25 ( 19 ) : 3067 – 3074 .
   Web of Science ®Google Scholar
• Tóth , G. , Molnár , S. , Tamás , T. and Borbély , I. 1997 . An efficient synthesis of 4,5‐dihydro‐3(2H)‐pyridazinone derivatives . Synth. Commun. , 27 ( 20 ) : 3513 – 3523 .
   Web of Science ®Google Scholar
• Davidson , D. and Bernhard , S. A. 1948 . The structure of Meldrum's supposed β‐lactonic acid . J. Am. Chem. Soc. , 70 ( 10 ) : 3426 – 3428 .
   Google Scholar
• Dhanoa , D. S. , Bagley , S. W. , Chang , R. S.L. , Lotti , V. J. , Chen , T. , Kivlighn , S. D. , Zingaro , G. J. , Siegl , P. K.S. , Chakravarty , P. K. , Patchett , A. A. and Greenlee , W. J. 1993 . (Dipropylphenoxy)phenylacetic acids: a new generation of nonpeptide angiotensin II receptor antagonists . J. Med. Chem. , 36 ( 23 ) : 3738 – 3742 . [PUBMED] [INFOTRIEVE] [CSA]
   Google Scholar
• McKillop , A. , Fiaud , J.‐C. and Hug , R. P. 1974 . The use of phase‐transfer catalysis for the synthesis of phenol ethers . Tetrahedron , 30 ( 11 ) : 1379 – 1382 . [CROSSREF]
   Google Scholar
• 2003/2004 . A Sigma‐Aldrich Company . Fluka Catalogue
   Google Scholar